NSK Ltd. ADS (NPSKY) Financials Nov 14, 2014, 8:10
NSK Ltd. ADS (NPSKY) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for NSK Ltd. ADS
Fiscal year is April-March. All values JPY millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 587.57B 710.43B 733.19B 732.84B 871.74B
Cost of Goods Sold (COGS) incl. D&A 480.17B 564.89B 587.06B 598.49B 689.01B
COGS excluding D&A 442.16B 529.19B 550.49B 563.17B 653.66B
Depreciation & Amortization Expense 38.02B 35.7B 36.57B 35.32B 35.35B
Depreciation - - - - -
Amortization of Intangibles - - - - -
Gross Income 107.4B 145.54B 146.13B 134.35B 182.73B
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 96.09B 102.02B 101.72B 101.99B 114.68B
Research & Development 8.79B 10.52B 10.37B 10.43B 9.92B
Other SG&A 87.3B 91.51B 91.34B 91.56B 104.76B
Other Operating Expense 0 0 0 0 0
Unusual Expense 1.26B 333M 744M 6.42B 16.27B
EBIT after Unusual Expense (1.26B) (333M) (744M) (6.42B) (16.27B)
Non Operating Income/Expense (2.07B) (4.72B) (1.74B) 85M 2.86B
Non-Operating Interest Income 815M 864M 748M 512M 658M
Equity in Affiliates (Pretax) 2.98B 3.57B 3.48B 3.63B 3.85B
Interest Expense 5.44B 4.66B 4.91B 4.87B 4.81B
Gross Interest Expense 5.44B 4.66B 4.91B 4.87B 4.81B
Interest Capitalized 0 0 0 0 0
Pretax Income 6.34B 38.24B 41.26B 25.3B 54.34B
Income Tax 820M 10.81B 11.88B 7.71B 20.53B
Income Tax - Current Domestic 5.03B 10.22B 10.28B 7.11B 18.58B
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic (4.21B) 586M 1.61B 600M 1.95B
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates - - - - -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 5.52B 27.43B 29.38B 17.59B 33.81B
Minority Interest Expense 750M 1.32B 863M 1.85B 2.65B
Net Income 4.77B 26.11B 28.51B 15.74B 31.17B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 4.77B 26.11B 28.51B 15.74B 31.17B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 4.77B 26.11B 28.51B 15.74B 31.17B
EPS (Basic) 8.82 48.30 52.75 29.14 57.70
Basic Shares Outstanding 540.59M 540.58M 540.56M 540.13M 540.12M
EPS (Diluted) - 48.29 52.75 29.14 57.63
Diluted Shares Outstanding - 540.72M 540.6M 540.13M 540.83M
EBITDA 49.32B 79.22B 80.99B 67.68B 103.4B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A 93.3 score in healthcare software deserves a second look. Not a victory lap, not a drumroll—just a serious look at whether the product is solving an annoying, expensive operational problem for specialty practices. NextPatient’s recognition in the 2026 KLAS Emerging Solutions Top 20 Report lands in that category. The company placed in the top five for improving...
Continue Reading
A $1.2 billion compliance bill has a way of making investors stop pretending controls are boring. Moore Law PLLC is urging Bank of America shareholders to contact the firm over allegations tied to the bank's anti-money-laundering and Bank Secrecy Act systems. The notice follows what it describes as landmark October 13, 2026 enforcement actions by the Treasury Department's...
Continue Reading
Wedding dresses are a miserable product to buy sight unseen, no matter how pretty the product photos look. That basic fact is why Azazie’s two East Coast pop-ups on November 21 and 22 deserve a closer look. This is not some grand retail rollout, and nobody should pretend a pair of short events rewrites the bridal market. But it is a practical test of where a...
Continue Reading
A spreadsheet can spot a cracked windshield, but it cannot tell you where the truck is headed. That is the useful, slightly irritating truth behind Seeking Alpha Premium’s 2026 pitch: it puts an enormous amount of stock-research machinery in one place, yet the investor still has to do the driving. Software Experts has highlighted the service in its review of...
Continue Reading
Orange sheet metal and flowering vines are an odd couple, which is precisely why this South Florida promotion has some bite. A plant marketer took a hard left turn Suntory Flowers put its Sun Parasol mandevillas alongside DGM Racing at Homestead-Miami Speedway, celebrating the millions of plants grown in South Florida. That is not a conventional horticulture play, and...
Continue Reading
Breathing trouble gets shrugged off far too easily, and that casual mistake has consequences. World COPD Day puts chronic obstructive pulmonary disease back in view, with the American Lung Association emphasizing a free Lung Health Navigator program for people living with COPD, their caregivers and families. This is not flashy medicine or a miracle-cure pitch. It is...
Continue Reading
What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...
Continue Reading
Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...
Continue Reading
Steel decarbonization announcements can sound enormous before a single bolt gets tightened. Utility Global says it plans to deploy its first industrial H2Gen project in India with Tata Steel, and that is plainly worth watching. Tata Steel is a serious industrial name, India is a consequential steel market, and any technology that can credibly lower emissions from heavy...
Continue Reading
A famous orthopedic name can open doors, but it cannot manufacture clinical evidence. That is the plain reality behind Vector Science and Therapeutics' new collaboration with the Andrews Research & Education Foundation. Dr. James Andrews carries enormous credibility in sports medicine, earned across more than five decades of work. For Vector, that association matters. For...
Continue Reading
Top 5 Most Recently Viewed Articles
Growing Demand for Aluminum Die Casting Machines The Aluminum Die Casting Machine market is set to experience notable growth, with expectations to reach a significant market value of around $4.2 billion soon. Projections indicate that this sector could expand at a compound annual growth rate (CAGR) of 6.5% over the upcoming years, potentially hitting approximately $7.3...
Continue Reading
Upcoming Class Action Against Match Group, Inc. (MTCH) The Gross Law Firm recently announced a class action notice aimed at shareholders of Match Group, Inc. (NASDAQ: MTCH). This notice serves as an important call to action for shareholders who purchased shares during a specified class period. The firm encourages these individuals to reach out regarding their potential...
Continue Reading
Unveiling Hidden Treasures of Giza at Cosmic Summit 2025 Get ready for an exciting event that promises to shed light on groundbreaking findings beneath the iconic Pyramids of Giza! The Cosmic Summit 2025 presents an exclusive opportunity for journalists to engage with distinguished researchers from the Khafre Research Project. Their innovative use of acoustic and radar...
Continue Reading
Understanding the Class Action Against WPP plc Recently, a significant class action lawsuit has been initiated against WPP plc (NYSE: WPP), raising important issues for its shareholders. The accusations suggest that the company's leadership misrepresented the reliability of its revenue forecasts and growth potential, all while downplaying risks associated with...
Continue Reading
Texaf's Strategic Development in Urban Infrastructure Texaf is taking significant strides in urban development with its recent project, the Petit-Pont building. The company is set to benefit from a substantial investment of EUR 5.39 million coming from the SFA Congo and African Rivers Fund IV LP. This initiative not only reflects Texaf's commitment to enhancing...
Continue Reading